Cargando…
Extraintestinal Manifestations of Inflammatory Bowel Disease
Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are frequent and may occur before or after IBD diagnosis. EIM may impact the quality of life for patients with IBD significantly requiring specific treatment depending on the affected organ(s). They most frequently affect joint...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511685/ https://www.ncbi.nlm.nih.gov/pubmed/26154136 http://dx.doi.org/10.1097/MIB.0000000000000392 |
_version_ | 1782382379491393536 |
---|---|
author | Vavricka, Stephan R. Schoepfer, Alain Scharl, Michael Lakatos, Peter L. Navarini, Alexander Rogler, Gerhard |
author_facet | Vavricka, Stephan R. Schoepfer, Alain Scharl, Michael Lakatos, Peter L. Navarini, Alexander Rogler, Gerhard |
author_sort | Vavricka, Stephan R. |
collection | PubMed |
description | Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are frequent and may occur before or after IBD diagnosis. EIM may impact the quality of life for patients with IBD significantly requiring specific treatment depending on the affected organ(s). They most frequently affect joints, skin, or eyes, but can also less frequently involve other organs such as liver, lungs, or pancreas. Certain EIM, such as peripheral arthritis, oral aphthous ulcers, episcleritis, or erythema nodosum, are frequently associated with active intestinal inflammation and usually improve by treatment of the intestinal activity. Other EIM, such as uveitis or ankylosing spondylitis, usually occur independent of intestinal inflammatory activity. For other not so rare EIM, such as pyoderma gangrenosum and primary sclerosing cholangitis, the association with the activity of the underlying IBD is unclear. Successful therapy of EIM is essential for improving quality of life of patients with IBD. Besides other options, tumor necrosis factor antibody therapy is an important therapy for EIM in patients with IBD. |
format | Online Article Text |
id | pubmed-4511685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-45116852015-08-03 Extraintestinal Manifestations of Inflammatory Bowel Disease Vavricka, Stephan R. Schoepfer, Alain Scharl, Michael Lakatos, Peter L. Navarini, Alexander Rogler, Gerhard Inflamm Bowel Dis Clinical Review Articles Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are frequent and may occur before or after IBD diagnosis. EIM may impact the quality of life for patients with IBD significantly requiring specific treatment depending on the affected organ(s). They most frequently affect joints, skin, or eyes, but can also less frequently involve other organs such as liver, lungs, or pancreas. Certain EIM, such as peripheral arthritis, oral aphthous ulcers, episcleritis, or erythema nodosum, are frequently associated with active intestinal inflammation and usually improve by treatment of the intestinal activity. Other EIM, such as uveitis or ankylosing spondylitis, usually occur independent of intestinal inflammatory activity. For other not so rare EIM, such as pyoderma gangrenosum and primary sclerosing cholangitis, the association with the activity of the underlying IBD is unclear. Successful therapy of EIM is essential for improving quality of life of patients with IBD. Besides other options, tumor necrosis factor antibody therapy is an important therapy for EIM in patients with IBD. Lippincott Williams & Wilkins 2015-07-02 2015-08 /pmc/articles/PMC4511685/ /pubmed/26154136 http://dx.doi.org/10.1097/MIB.0000000000000392 Text en Copyright © 2015 Crohn's & Colitis Foundation of America, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Review Articles Vavricka, Stephan R. Schoepfer, Alain Scharl, Michael Lakatos, Peter L. Navarini, Alexander Rogler, Gerhard Extraintestinal Manifestations of Inflammatory Bowel Disease |
title | Extraintestinal Manifestations of Inflammatory Bowel Disease |
title_full | Extraintestinal Manifestations of Inflammatory Bowel Disease |
title_fullStr | Extraintestinal Manifestations of Inflammatory Bowel Disease |
title_full_unstemmed | Extraintestinal Manifestations of Inflammatory Bowel Disease |
title_short | Extraintestinal Manifestations of Inflammatory Bowel Disease |
title_sort | extraintestinal manifestations of inflammatory bowel disease |
topic | Clinical Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511685/ https://www.ncbi.nlm.nih.gov/pubmed/26154136 http://dx.doi.org/10.1097/MIB.0000000000000392 |
work_keys_str_mv | AT vavrickastephanr extraintestinalmanifestationsofinflammatoryboweldisease AT schoepferalain extraintestinalmanifestationsofinflammatoryboweldisease AT scharlmichael extraintestinalmanifestationsofinflammatoryboweldisease AT lakatospeterl extraintestinalmanifestationsofinflammatoryboweldisease AT navarinialexander extraintestinalmanifestationsofinflammatoryboweldisease AT roglergerhard extraintestinalmanifestationsofinflammatoryboweldisease |